MYi Diagnostics and Discovery

MYi Diagnostics and Discovery is a small biotechnology company based in San Francisco, California. With 5 to 9 employees, the company generates an annual revenue of $1 million. MYi Diagnostics and Discovery focuses on developing innovative diagnostic assays for a variety of applications. The company specializes in creating cost-effective, highly sensitive, and multi-analyte assays that can analyze the molecular content of blood and individual cells. These assays are designed for longitudinal profiling, allowing for the monitoring of healthy individuals, those predisposed to diseases, and patients undergoing treatment. MYi also develops multiplexed immunocytochemical platforms for analyzing patient biopsies to identify disease-specific biomarkers. MYi Diagnostics and Discovery's assays are designed to provide actionable information for medical professionals, enabling them to make accurate diagnoses and prescribe the most appropriate treatments. This personalized approach to medicine aligns with the company's mission to enable precision healthcare through its innovative diagnostic technologies. For more information about MYi Diagnostics and Discovery's products and services, please visit their website at myidiagnostics.com.